Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

GU Cancers 2019 | Combined blockade of VEGF and PD-1 signaling in RCC

Michael Atkins, MD, of Georgetown University, Washington, DC, discusses the issues involved in the combined blockade of vascular endothelial growth factor (VEGF) and programmed death 1 (PD-1) signaling in renal cell carcinoma (RCC). This video was recorded at the 2019 Genitourinary Cancers Symposium, held in San Francisco, CA.